Last update:
Medications news
Medications
Pills that communicate from the stomach could improve medication adherence
In an advance that could help ensure people are taking their medication on schedule, MIT engineers have designed a pill that can report when it has been swallowed.
4 minutes ago
0
0
Medications
Longer treatment with medications for opioid use disorder associated with greater probability of survival
A new study of over 32,000 US veterans has found that the longer people stay on medications for opioid use disorder (buprenorphine, methadone, or extended-release naltrexone), the greater the probability of short- and medium-term ...
4 hours ago
0
0
Cholesterol-lowering drug can overcome chemotherapy resistance in triple-negative breast cancer, researchers discover
Triple-negative breast cancer (TNBC) is among the most aggressive types of breast cancer, lacking estrogen, progesterone, and HER2 receptors and thus relying primarily on cytotoxic chemotherapy. Despite initial responsiveness, ...
16 hours ago
0
46
In the UK, 1.6 million adults used weight loss drugs in the past year
An estimated 1.6 million adults in England, Wales and Scotland used drugs such as Wegovy and Mounjaro to help lose weight between early 2024 and early 2025, according to a new study by UCL (University College London) researchers.
10 hours ago
0
0
Ozempic, Wegovy might lower colon cancer risk
Ozempic and Wegovy might help people avoid colon cancer as well as promote weight loss or control diabetes, a new study says.
17 hours ago
0
0
How eggs can help you come off Wegovy: Cracking the problem of weight-regain
For millions of people, weight-loss injections such as Wegovy and Mounjaro have felt like a breakthrough that finally makes eating less feel easier. In a few short years, these so-called GLP-1 drugs have reshaped how obesity ...
Jan 6, 2026
0
0
Novo Nordisk launches daily weight-loss pill to expand GLP-1 access
A daily pill for weight loss has officially arrived in the U.S.
Jan 6, 2026
0
0
FDA approves Myqorzo for symptomatic obstructive hypertrophic cardiomyopathy
The U.S. Food and Drug Administration has approved Myqorzo (aficamten) for the treatment of adults with symptomatic obstructive hypertrophic cardiomyopathy (oHCM). Approval of Myqorzo was granted to Cytokinetics.
Jan 6, 2026
0
0
Combination therapy against brain cancer proves effective in preclinical models
Researchers at the UNC School of Medicine and the UNC Eshelman School of Pharmacy have made a breakthrough that could modernize treatment for glioblastoma. In a study published in Proceedings of the National Academy of Sciences, ...
Jan 5, 2026
0
24
Trump says he takes high-dose aspirin, links it to hand bruising
President Donald Trump, 79, says he takes a higher daily dose of aspirin than his doctors recommend, a choice he says explains the bruising that's often seen on his hands.
Jan 5, 2026
0
0
Coloradans snap up over-the-counter naloxone while hospitals offer the overdose-reversal drug to more patients
Colorado is coming closer to universal access to overdose-reversing medication as residents snap up an over-the-counter version and hospitals offer it to more patients.
Dec 31, 2025
0
0
Visiting abroad in the coming year? Antibiotics becoming less effective against traveler's diarrhea, study warns
Planning some international travel as one of your New Year's resolutions?
Dec 30, 2025
0
1
FDA approves Jascayd for progressive pulmonary fibrosis
The U.S. Food and Drug Administration has approved Jascayd (nerandomilast) tablets for the treatment of progressive pulmonary fibrosis in adults.
Dec 30, 2025
0
1
Tirzepatide noninferior to dulaglutide for CV outcomes in type 2 diabetes
Tirzepatide is noninferior to dulaglutide with respect to a composite of death from cardiovascular (CV) causes, myocardial infarction, or stroke among patients with type 2 diabetes and atherosclerotic CV disease, according ...
Dec 30, 2025
0
0
Prescribing of some controlled medications has decreased in youth over past two decades
In the past two decades, there were decreases in prescribing of some controlled medications to adolescents and young adults, according to a study published online Dec. 15 in Drug and Alcohol Dependence.
Dec 30, 2025
0
0
New antivirals are being tested for herpesviruses, and scientists now know how they work
Harvard Medical School researchers have uncovered crucial insights into how an emerging class of antiviral drugs works.
Dec 29, 2025
0
41
Breast cancer drug boosts leukemia treatment: Unexpected duo shows promise in overcoming resistance
A research team at Oregon Health & Science University has discovered a promising new drug combination that may help people with acute myeloid leukemia overcome resistance to one of the most common frontline therapies.
Dec 29, 2025
0
97
Email reminders boost use of database for safe prescribing
A new randomized clinical trial finds that simple reminder emails substantially increase clinicians' use of a database that supports safe prescribing of opioids and other drugs, even though opioid prescribing patterns themselves ...
Dec 29, 2025
0
0
New study suggests best way to stop taking antidepressants
The best way for people with depression to stop taking antidepressants once their condition improves is to slowly taper off the medication while also receiving psychological support, new research suggested Thursday.
Dec 27, 2025
0
44
Worried about statins? Here's what the evidence shows
Few medicines have sparked as much debate as statins. Cardiologists often describe them as life-saving, while some patients remain wary of side effects or uneasy about taking a daily pill.
Dec 26, 2025
0
3
Iron-snatching compounds found to be effective against parasitic flatworm
A series of compounds that deprive iron essential for a parasitic worm could provide effective new agents for blocking parasite growth, a RIKEN researcher has found. This finding, published in the journal Tropical Medicine ...
Dec 23, 2025
0
31
Novo Nordisk says US approves first GLP-1 pill for weight loss
Danish pharmaceutical giant Novo Nordisk announced Monday the US Food and Drug Administration (FDA) had approved its popular GLP-1 anti-obesity drug Wegovy to be administered in pill form for weight loss.
Dec 23, 2025
0
0
FDA approves first subcutaneous drug for EGFR-mutated non-small cell lung cancer
The U.S. Food and Drug Administration has approved Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the first and only subcutaneously administered therapy for patients with epidermal growth factor receptor (EGFR)-mutated ...
Dec 23, 2025
0
1
Antiviral trial ties valacyclovir to faster cognitive decline
New York State Psychiatric Institute and Columbia University Medical Center investigators, with co-authors across additional US centers, report greater cognitive worsening at 78 weeks with valacyclovir than with placebo among ...
Cannabis products with more THC can slightly reduce pain but cause more side effects
A new systematic evidence review finds that cannabis products that carry relatively high levels of the psychoactive compound tetrahydrocannabinol, commonly known as THC, may provide short-term improvements in pain and function.
Dec 22, 2025
0
2
